Embla Medical hf (OTCPK:OSSFF)
$ 4.15 (0%) Market Cap: 1.68 Bil Enterprise Value: 2.15 Bil PE Ratio: 20.04 PB Ratio: 1.91 GF Score: 92/100

Q3 2025 Embla Medical hf Earnings Call Transcript

Oct 21, 2025 / 07:00 AM GMT
Release Date Price: $4.8

Key Points

Positve
  • Embla Medical hf (OSSFF) reported a 7% organic growth in sales for Q3 2025, with a total reported growth of 11% including FX and M&A impacts.
  • The company's prosthetics and neuro orthotics segments experienced strong momentum, with organic growth of 13% in the third quarter.
  • Embla Medical hf (OSSFF) successfully launched the Odyssey IQ, a new hydraulic microprocessor foot solution, which received a positive market reception in the Americas.
  • The company achieved a strong EBITDA margin of 22% for the quarter, maintaining its performance from the previous year.
  • Embla Medical hf (OSSFF) reiterated its full-year guidance, expecting 5-6% organic growth and a 20-21% EBITDA margin, indicating confidence in its strategic direction.
Negative
  • The patient care segment showed modest growth of only 1% for the quarter, with performance below market expectations.
  • Embla Medical hf (OSSFF) faced challenges in the US market due to tariffs, impacting profitability and requiring mitigation strategies.
  • The company experienced internal disruptions in its patient care business due to rebranding and system integration initiatives, affecting growth.
  • Bracing and support sales remained flat, with the US market particularly impacted by tariffs and channel structure changes.
  • The potential impact of a US Department of Commerce investigation into medical consumables and equipment remains uncertain, posing a risk to future operations.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EMBLA.CO - Embla Medical hf
Q3 2025 Embla Medical hf Earnings Call
Oct 21, 2025 / 07:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
At this time I would like to welcome everyone to this Q3 2025 conference call. Today's call is being recorded. If you have any objections, please disconnect at this time. All participants will be on listen no mode throughout the presentation, and afterwards there'll be a question-and-answer session.

I would now like to introduce President and CEO Sven Silverson and CFO Anna Svensader. I will now send the call over to your speakers. You may now begin your presentation.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and good morning and welcome to the ATLA
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot